Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Adoption remained modest until recent years as GLP-1 drug claims rose from 6.9 percent in 2023 to 10.5 percent in 2025
Zepbound has received FDA approval for weight loss
However, high discontinuation rates, driven primarily by gastrointestinal adverse events, posed a significant barrier to achieving these outcomes
They rank higher than Glumetza (metformin), but lower than newer injectable drugs, such as Mounjaro (tirzepatide)
Approximate dose equivalency Based on weight loss efficacy data from clinical trials: The 7.5 mg tirzepatide dose roughly corresponds to 1.7 mg of semaglutide based on weight loss percentages observed in the SURMOUNT and STEP clinical trials
The injectable delivery method bypasses digestive limitations, ensuring maximum absorption and rapid systemic distribution, which makes it a preferred option among patients seeking measurable results in clinical or supervised wellness settings
US$ 26.35
US$ 26.92
US$ 24.42
